Search - tctmd.com

Displaying 141 - 160 of 247

Sort: Relevancy | Date

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Daily News

Signal of Aortic Stenosis Risk With Celecoxib

Michael O'Riordan

March 05, 2019

News Daily News

Better TAVR Outcomes With More Experienced Operators: New York Database

Michael O'Riordan

December 12, 2018

News Daily News

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

Michael O'Riordan

November 09, 2018

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Conference News The Structural Heart Disease Summit 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

Michael O'Riordan

March 27, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

Advertisement

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Signal of Aortic Stenosis Risk With Celecoxib

Better TAVR Outcomes With More Experienced Operators: New York Database

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

High Mortality but Durable Results With Valve-in-Valve TAVR

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

Ticagrelor: Better Platelet Blockade Post-TAVR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content